Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan

• Váldodahkkit: Dana Dadanbekova (Dahkki), Kairat Zhakipbekov (Dahkki), Almat Kodasbayev (Dahkki), Ubaidilla Datkhayev (Dahkki), Guenka Petrova (Dahkki), Konstantin Tachkov (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Pensoft Publishers, 2024-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The objective of this study is to evaluate the quality of life (QoL) of hospitalised patients with cardiomyopathy (CM) treated with a fixed dose combination (FDC) of sacubitril/valsartan, or standard therapy in Kazakhstan during or after COVID-19. This is an observational study of patients with inci...